COVID‐19 immunopathology: from acute diseases to chronic sequelae
The clinical manifestation of coronavirus disease 2019 (COVID‐19) mainly targets the lung
as a primary affected organ, which is also a critical site of immune cell activation by severe …
as a primary affected organ, which is also a critical site of immune cell activation by severe …
Deciphering SARS-CoV-2 virologic and immunologic features
G Lebeau, D Vagner, E Frumence, F Ah-Pine… - International journal of …, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus (SARS-CoV)-2 and its associated
pathology, COVID-19, have been of particular concerns these last months due to the …
pathology, COVID-19, have been of particular concerns these last months due to the …
The dynamic changes in cytokine responses in COVID-19: a snapshot of the current state of knowledge
M Buszko, JH Park, D Verthelyi, R Sen, HA Young… - Nature …, 2020 - nature.com
“The role of cytokines in COVID-19” online symposium was presented on 18 June 2020 by
the NIH/FDA Immunology and Cytokine Interest Groups and was purposed to discuss our …
the NIH/FDA Immunology and Cytokine Interest Groups and was purposed to discuss our …
COVID-19 patients display distinct SARS-CoV-2 specific T-cell responses according to disease severity
M Kroemer, L Spehner, L Vettoretti, A Bouard… - Journal of Infection, 2021 - Elsevier
Adaptive Immune responses generated by SARS-CoV-2 virus in convalescent patients
according to disease severity remain poorly characterized. To this end, we designed a …
according to disease severity remain poorly characterized. To this end, we designed a …
A longitudinal study of immune cells in severe COVID-19 patients
D Payen, M Cravat, H Maadadi, C Didelot… - Frontiers in …, 2020 - frontiersin.org
Little is known about the time-dependent immune responses in severe COVID-19. Data of
15 consecutive patients were sequentially recorded from intensive care unit admission …
15 consecutive patients were sequentially recorded from intensive care unit admission …
Immunomodulation as treatment for severe coronavirus disease 2019: a systematic review of current modalities and future directions
EA Meyerowitz, P Sen, SR Schoenfeld… - Clinical Infectious …, 2021 - academic.oup.com
In severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, viral load
peaks early and declines quickly after symptom onset. Severe coronavirus disease 2019 …
peaks early and declines quickly after symptom onset. Severe coronavirus disease 2019 …
Characterization of SARS-CoV-2 evasion: interferon pathway and therapeutic options
M Znaidia, C Demeret, S van der Werf, AV Komarova - Viruses, 2022 - mdpi.com
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is responsible for the
current COVID-19 pandemic. SARS-CoV-2 is characterized by an important capacity to …
current COVID-19 pandemic. SARS-CoV-2 is characterized by an important capacity to …
Understanding the complexities of SARS-CoV2 infection and its immunology: A road to immune-based therapeutics
V Kumar - International Immunopharmacology, 2020 - Elsevier
Emerging infectious diseases always pose a threat to humans along with plant and animal
life. SARS-CoV2 is the recently emerged viral infection that originated from Wuhan city of the …
life. SARS-CoV2 is the recently emerged viral infection that originated from Wuhan city of the …